HKU Gets Green Light For Nasal Covid Vaccine Trials
"); jQuery("#212 h3").html("
"); });
2020-09-09 HKT 19:19
Share this story
The University of Hong Kong says mainland authorities have allowed clinical trials of a nasal spray vaccine for Covid-19 it has been developing with mainland institutions.
The State Key Laboratory of Emerging Infectious Diseases of the university's Department of Microbiology has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.
It says it is the only nasally-administered vaccine against the disease to be allowed for clinical trials so far by the National Medical Products Administration.
HKMA Warns Of Fake Stablecoins As Licensed Issuers Have Yet To Launch Tokens
The Hong Kong Monetary Authority (HKMA) has warned the public about fake stablecoins in Hong Kong, specifically flaggin... Read more
Tazapay Secures Money Service Operator License In Hong Kong
Singapore-based cross-border payments company Tazapay has secured a Money Service Operator (MSO) license in Hong Kong. ... Read more
Livi Bank Posts First Full-Year Profit In 2025 As Loans Rise 49%
Hong Kong digital bank livi bank reported a full-year profit of HK$21 million for 2025. For the year, total operating i... Read more
FWD Group Reports US$720M In New Business Sales As Expansion Continues
FWD Group reported a 4% year-on-year increase in new business sales to US$720 million for the first quarter of 2026, dr... Read more
WeLab Bank 2025 Revenue Hits HK$942M After Securing First-Half Profitability
WeLab Bank achieved profitability in the first half of 2025 and reported a 35% year-on-year revenue increase to HK$942 ... Read more
Ripple And Kbank Roll Out Institutional Digital Asset Wallet In South Korea
Ripple has partnered with Kbank to deploy an institutional digital asset wallet in Korea, equipping the internet bank w... Read more